Literature DB >> 8690638

Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation.

C C Ling1, C Burman, C S Chui, G J Kutcher, S A Leibel, T LoSasso, R Mohan, T Bortfeld, L Reinstein, S Spirou, X H Wang, Q Wu, M Zelefsky, Z Fuks.   

Abstract

PURPOSE: To implement radiotherapy with intensity-modulated beams, based on the inverse method of treatment design and using a multileaf collimation system operating in the dynamic mode. METHODS AND MATERIALS: An algorithm, based on the inverse technique, has been integrated into the radiotherapy treatment-planning computer system in our Center. This method of computer-assisted treatment design was used to derive intensity-modulated beams to optimize the boost portion of the treatment plan for a patient with a T1c cancer of the prostate. A dose of 72 Gy (in 40 fractions) was given with a six-field plan, and an additional 9 Gy (in five fractions) with six intensity-modulated beams. The intensity-modulated fields were delivered using dynamic multileaf collimation, that is, individual leaves were in motion during radiation delivery, with the treatment machine operating in the clinical mode. Exhaustive quality assurance measurement and monitoring were carried out to ensure safe and accurate implementation.
RESULTS: Dose distribution and dose-volume histogram of the "inverse method" boost plan and of the composite (72 Gy primary + 9 Gy boost) plan were judged clinically acceptable. Compared to a manually designed boost plan, the inverse treatment design gave improved conformality and increased dose homogeneity in the planning target volume. Film and ion chamber dosimetry, performed prior to the first treatment, indicated that each of the six intensity-modulated fields was accurately produced. Thermoluminescent dosimeter (TLD) measurements performed on the patient confirmed that the intended dose was delivered in the treatment. In addition, computer-aided treatment-monitoring programs assured that the multileaf collimator (MLC) position file was executed to the specified precision. In terms of the overall radiation treatment process, there will likely be labor savings in the planning and the treatment phases.
CONCLUSIONS: We have placed into clinical use an integrated system of conformal radiation treatment that incorporated the inverse method of treatment design and the use of dynamic multileaf collimation to deliver intensity-modulated beams. The system can provide better treatment design, which can be implemented reliably and safely. We are hopeful that improved treatment efficacy will result.

Entities:  

Mesh:

Year:  1996        PMID: 8690638     DOI: 10.1016/0360-3016(96)00174-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  56 in total

1.  [Inverse radiotherapy planning].

Authors:  W Schlegel; P Kneschaurek
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

Review 2.  Technological advances in radiation therapy for prostate cancer.

Authors:  Mehee Choi; Arthur Y Hung
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

3.  Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.

Authors:  Justin E Bekelman; Nandita Mitra; Jason Efstathiou; Kaijun Liao; Robert Sunderland; Deborah N Yeboa; Katrina Armstrong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-16       Impact factor: 7.038

4.  Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data.

Authors:  Yun Liang; Karen Messer; Brent S Rose; John H Lewis; Steve B Jiang; Catheryn M Yashar; Arno J Mundt; Loren K Mell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-14       Impact factor: 7.038

5.  Intensity modulated radiation therapy.

Authors:  C M Rose
Journal:  West J Med       Date:  1998-11

Review 6.  The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer.

Authors:  Zhengfei Zhu; Xiaolong Fu
Journal:  Transl Lung Cancer Res       Date:  2015-06

7.  Automated prediction of dosimetric eligibility of patients with prostate cancer undergoing intensity-modulated radiation therapy using a convolutional neural network.

Authors:  Tomohiro Kajikawa; Noriyuki Kadoya; Kengo Ito; Yoshiki Takayama; Takahito Chiba; Seiji Tomori; Ken Takeda; Keiichi Jingu
Journal:  Radiol Phys Technol       Date:  2018-08-14

8.  Repeat Radiation for Local Recurrence of Head and Neck Tumors and in Prostate Cancer.

Authors:  Arne Grün; Thomas Kuhnt; Thorsten Schlomm; Heidi Olze; Volker Budach; Carmen Stromberger
Journal:  Dtsch Arztebl Int       Date:  2020-03-06       Impact factor: 5.594

9.  New approach in lung cancer radiotherapy offers better normal tissue sparing.

Authors:  Ivaylo B Mihaylov
Journal:  Radiother Oncol       Date:  2016-09-28       Impact factor: 6.280

10.  Risk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancer.

Authors:  Dong Wook Kim; Weon Kuu Chung; Dongoh Shin; Seongeon Hong; Sung Ho Park; Sung-Yong Park; Kwangzoo Chung; Young Kyung Lim; Dongho Shin; Se Byeong Lee; Hyun-Ho Lee; Myonggeun Yoon
Journal:  Radiat Oncol       Date:  2013-03-04       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.